Blueprint Medicines Corporation (0HOJ.L)
USD 97.85
(1.4%)
USD 97.85
(1.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 249.38 Million | 204.03 Million | 180.08 Million | 793.73 Million | 66.51 Million | 44.52 Million |
| Cost of Revenue | 12.79 Million | 17.81 Million | 17.93 Million | 425 Thousand | - | 243.62 Million |
| Gross Profit | 236.58 Million | 186.22 Million | 162.14 Million | 793.31 Million | 66.51 Million | -199.1 Million |
| Operating Expenses | 722.86 Million | 723.74 Million | 804.12 Million | 484.6 Million | 427.83 Million | 291.54 Million |
| Selling, General and Administrative Expenses | 295.14 Million | 237.37 Million | 195.29 Million | 157.74 Million | 96.38 Million | 47.92 Million |
| Research and Development Expenses | 427.72 Million | 477.41 Million | 601.03 Million | 326.86 Million | 331.45 Million | 243.62 Million |
| Other Expenses | - | 8.94 Million | 7.8 Million | -366 Thousand | -100 Thousand | 10.45 Million |
| Cost and Expenses | 735.65 Million | 741.55 Million | 822.06 Million | 485.02 Million | 427.83 Million | 291.54 Million |
| Operating Income | -486.27 Million | -549.25 Million | -648.46 Million | 302.14 Million | -366.58 Million | -247.02 Million |
| Interest Expense | - | 16.76 Million | - | - | 13.73 Million | 73 Thousand |
| Income Tax Expense | 968 Thousand | 5.23 Million | 3 Million | 1.05 Million | -18.99 Million | 10.45 Million |
| Earnings before Tax | -506.01 Million | -552.28 Million | -641.08 Million | 314.94 Million | -347.69 Million | -236.64 Million |
| Net Income | -506.98 Million | -557.51 Million | -644.08 Million | 313.88 Million | -328.7 Million | -236.64 Million |
| Earnings Per Share Basic | -8.37 | -9.35 | -11.01 | 5.76 | -6.87 | -5.39 |
| Earnings Per Share Diluted | -8.37 | -9.35 | -11.01 | 5.59 | -6.87 | -5.39 |
| Weighted Average Shares Outstanding | 60.55 Million | 59.64 Million | 58.51 Million | 54.53 Million | 47.82 Million | 43.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 60.55 Million | 59.64 Million | 58.51 Million | 56.16 Million | 47.82 Million | 43.86 Million |
| Gross Margin | 0.95 | 0.91 | 0.90 | 1.00 | 1.00 | -4.47 |
| EBIT Margin | -1.90 | -2.63 | -3.56 | 0.39 | -5.43 | -5.31 |
| Profit Margin | -2.03 | -2.73 | -3.58 | 0.40 | -4.94 | -5.32 |
| EBITDA | -474.61 Million | -515.41 Million | -628.29 Million | 308.7 Million | -356.06 Million | -242.78 Million |
| Earnings Before Tax Margin | -1.95 | -2.69 | -3.60 | 0.38 | -5.51 | -5.55 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 128.18 Million | 138.15 Million | 96.11 Million | 71.95 Million | 249.38 Million | 56.56 Million |
| Cost of Revenue | 1.93 Million | 11.21 Million | 8 Million | 1.79 Million | 24.46 Million | 4.55 Million |
| Gross Profit | 126.25 Million | 126.94 Million | 88.11 Million | 70.16 Million | 224.91 Million | 52.01 Million |
| Operating Expenses | 175.22 Million | 169.99 Million | 166.93 Million | 175.27 Million | 711.19 Million | 180.99 Million |
| Selling, General and Administrative Expenses | 89.92 Million | 89.33 Million | 83.55 Million | 79.27 Million | - | 70.74 Million |
| Research and Development Expenses | 85.3 Million | 80.65 Million | 83.38 Million | 96 Million | - | 110.25 Million |
| Other Expenses | - | -1000.00 | 376 Thousand | -577 Thousand | -946 Thousand | -728 Thousand |
| Cost and Expenses | 177.15 Million | 181.2 Million | 174.93 Million | 177.06 Million | 735.65 Million | 185.54 Million |
| Operating Income | -48.97 Million | -43.04 Million | -78.82 Million | -105.11 Million | -486.27 Million | -128.98 Million |
| Interest Expense | 18.76 Million | 16.8 Million | 15.07 Million | 15 Million | 51.6 Million | -3.8 Million |
| Income Tax Expense | 273 Thousand | 102 Thousand | 180 Thousand | 61 Thousand | 968 Thousand | 197 Thousand |
| Earnings before Tax | -56 Million | -49.89 Million | 89.31 Million | -110.85 Million | -506.01 Million | -133.51 Million |
| Net Income | -56.27 Million | -49.99 Million | 89.13 Million | -110.91 Million | -506.98 Million | -133.71 Million |
| Earnings Per Share Basic | -0.89 | -0.80 | 1.45 | -1.82 | - | -2.20 |
| Earnings Per Share Diluted | -0.89 | -0.80 | 1.40 | -1.82 | - | -2.20 |
| Weighted Average Shares Outstanding | 63.38 Million | 62.85 Million | 61.58 Million | 60.89 Million | 60.55 Million | 60.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 63.38 Million | 62.85 Million | 63.8 Million | 60.89 Million | 60.55 Million | 60.68 Million |
| Gross Margin | 0.98 | 0.92 | 0.92 | 0.98 | 0.90 | 0.92 |
| EBIT Margin | -0.26 | -0.29 | -0.77 | -1.44 | - | -2.28 |
| Profit Margin | -0.44 | -0.36 | 0.93 | -1.54 | -2.03 | -2.36 |
| EBITDA | -33.37 Million | -39.42 Million | -74.01 Million | -103.57 Million | - | -128.98 Million |
| Earnings Before Tax Margin | -0.38 | -0.31 | -0.82 | -1.46 | -1.95 | -2.28 |
0058
ENTRA
ABANF
INDSILHYD
LAFFANSQ
AIM